2023
DOI: 10.1016/j.cej.2023.145703
|View full text |Cite
|
Sign up to set email alerts
|

Noncovalent co-assembly of aminoglycoside antibiotics@tannic acid nanoparticles for off-the-shelf treatment of pulmonary and cutaneous infections

Guang Yang,
Changrong Wang,
Yaping Wang
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 51 publications
0
3
0
Order By: Relevance
“…Cip-CB self-assembled in water to form Cip-CBMS. Finally, they loaded 5,10,15,20-tetraphenylporphyrin (TPP) onto the Cip-CBMS surface to form multifunctional antimicrobial magnocellular micelles TPP@Cip-CBMS (Yang, Song, Dong, et al, 2023;Yang, Song, Yin, et al, 2023;Yang, Wang, Wang, et al, 2023). In an acidic biofilm microenvironment, the carboxyl groups in TPP@Cip-CBMS are protonated, thereby giving the micelles positive charges.…”
Section: Drug-pdtmentioning
confidence: 99%
See 2 more Smart Citations
“…Cip-CB self-assembled in water to form Cip-CBMS. Finally, they loaded 5,10,15,20-tetraphenylporphyrin (TPP) onto the Cip-CBMS surface to form multifunctional antimicrobial magnocellular micelles TPP@Cip-CBMS (Yang, Song, Dong, et al, 2023;Yang, Song, Yin, et al, 2023;Yang, Wang, Wang, et al, 2023). In an acidic biofilm microenvironment, the carboxyl groups in TPP@Cip-CBMS are protonated, thereby giving the micelles positive charges.…”
Section: Drug-pdtmentioning
confidence: 99%
“…To deal with infections caused by drug‐resistant bacteria, current clinical practice often involves the utilization of high‐dose antibiotic therapy or a combination of multiple antibiotics (Courjon & Del Guidice, 2021; Michelangeli et al, 2018; Vincent et al, 2016). Antibiotics commonly employed in clinical practice can be categorized into the following seven groups based on their chemical structures: (1) β‐lactam antibiotics (e.g., penicillins, cephalosporins) (Lima et al, 2020; Zabiszak et al, 2023); (2) Macrolide antibiotics (e.g., erythromycin, azithromycin) (Chen, Gao, et al, 2023; Chen, Leimer, et al, 2023; Chen, Qi, et al, 2023; Fostier et al, 2023); (3) Peptide antibiotics (e.g., vancomycin, polymyxin) (Tian, Shi, et al, 2023; Tian, Su, et al, 2023); (4) Aminoglycoside antibiotics (e.g., streptomycin, kanamycin) (Dove et al, 2022; Yang, Song, Dong, et al, 2023; Yang, Song, Yin, et al, 2023; Yang, Wang, Wang, et al, 2023); (5) Tetracycline antibiotics (e.g., tetracycline, doxycycline) (Grossman, 2016; LaPlante et al, 2022); (6) Quinolone antibiotics (e.g., ciprofloxacin, ofloxacin) (Pham et al, 2019); (7) Sulfonamide antibiotics (e.g., sulfadiazine) (Zhu, Pang, et al, 2022; Zhu, Wang, et al, 2022). Furthermore, certain antimicrobial peptides and surface‐active substances have also demonstrated the ability to eliminate bacteria or suppress genes associated with biofilm synthesis (Xuan et al, 2023).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation